HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway.

Abstract
Ceramide, a tumor-suppressor lipid, is generated by sphingomyelin hydrolysis or by de novo synthesis when cells are activated by various stress stimuli as well as when cancer cells are subjected to genotoxic chemotherapy. Ceramide may modulate apoptotic signaling pathways; however, its transcription-dependent effects remain unclear. Our data showed that actinomycin D partially inhibited ceramide-induced apoptosis. Using microarray analysis, we found that ceramide up-regulated a tumor suppressor gene called thioredoxin-interacting protein (Txnip). Similarly, the chemotherapeutic agent etoposide induced Txnip expression en route to apoptosis, which was blocked by inhibitors of ceramide production. Txnip colocalized with thioredoxin and reduced its activity, which caused dissociation of thioredoxin from apoptosis signal-regulating kinase 1 (ASK1). Cells expressing ASK1 siRNA were more resistant to ceramide-induced apoptosis. Ceramide caused ASK1-regulated p38 mitogen-activated protein kinase (MAPK) and JNK activation, as well as activation of the endoplasmic reticulum (ER) stress cascade, and pharmacologic or siRNA-mediated inhibition of p38 MAPK or JNK partially reduced ceramide-induced mitochondria-mediated apoptosis. Furthermore, ceramide-induced ASK1, p38, and JNK phosphorylation and cell apoptosis were inhibited by Txnip siRNA transfection. Taken together, we show that ceramide exhibits a mechanism of transcriptional regulation involving up-regulation of Txnip expression, also induced by etoposide, which results in ASK1 activation, ER stress, and p38 and JNK phosphorylation, all leading to apoptosis.
AuthorsChia-Ling Chen, Chiou-Feng Lin, Wen-Tsan Chang, Wei-Ching Huang, Chiao-Fang Teng, Yee-Shin Lin
JournalBlood (Blood) Vol. 111 Issue 8 Pg. 4365-74 (Apr 15 2008) ISSN: 0006-4971 [Print] United States
PMID18270325 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Ceramides
  • RNA, Messenger
  • TXNIP protein, human
  • Dactinomycin
  • Thioredoxins
  • Etoposide
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 5
  • MAP3K5 protein, human
Topics
  • Animals
  • Apoptosis (drug effects)
  • Carrier Proteins (genetics, metabolism)
  • Ceramides (pharmacology)
  • Dactinomycin (pharmacology)
  • Down-Regulation (drug effects)
  • Enzyme Activation (drug effects)
  • Etoposide (pharmacology)
  • Gene Expression Regulation, Leukemic (drug effects)
  • Humans
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Jurkat Cells
  • MAP Kinase Kinase Kinase 5 (metabolism)
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • Phosphorylation (drug effects)
  • Protein Transport (drug effects)
  • RNA, Messenger (genetics, metabolism)
  • Thioredoxins (metabolism)
  • Transcription, Genetic (drug effects)
  • Up-Regulation (drug effects)
  • p38 Mitogen-Activated Protein Kinases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: